Invented by Kamal Khan Mubarak, Eman Azra Mubarak, Individual

The ACE2 receptor is a protein that plays a crucial role in regulating blood pressure and cardiovascular function. However, it has also been identified as the primary receptor for the SARS-CoV-2 virus, which causes COVID-19. As such, there has been a significant interest in developing compositions and methods for modulating the ACE2 receptor. The market for compositions for modulating the ACE2 receptor is rapidly growing, with many companies and research institutions investing in this area. These compositions can be used for a variety of purposes, including treating hypertension, heart failure, and other cardiovascular diseases, as well as preventing or treating COVID-19. One of the most promising areas of research involves developing small molecule inhibitors that can bind to the ACE2 receptor and prevent the SARS-CoV-2 virus from entering cells. Several companies are currently working on developing these inhibitors, and early results have been promising. Another area of research involves developing antibodies that can bind to the ACE2 receptor and prevent the virus from entering cells. Several companies are currently working on developing these antibodies, and some have already entered clinical trials. In addition to these approaches, there are also efforts to develop natural compounds that can modulate the ACE2 receptor. For example, some studies have shown that certain plant extracts can inhibit the ACE2 receptor and may have potential therapeutic benefits. Overall, the market for compositions for modulating the ACE2 receptor is expected to continue to grow in the coming years. With the ongoing COVID-19 pandemic, there is a significant need for effective treatments and preventative measures, and modulating the ACE2 receptor is one potential avenue for achieving these goals. As such, we can expect to see continued investment and research in this area, with the hope of developing effective and safe treatments for a range of diseases and conditions.

The Individual invention works as follows

Disclosed in certain embodiments are compositions and methods for treating coronavirus related adverse events with an angiotensin-converting enzyme 2 (ACE2) receptor modulator.

Background for Compositions for modulating the ace2 receptor: compositions and methods

Pharmaceutical Compositions

EXAMPLES

Example 1

Medication Use of COVID-19 Positive Patients and Negative Patients”.

Methods

Results

Any Antihistamine Use (H1 or H2)

Antihistamine Use (H1 Only)

Antihistamine Use (H2 Only)

Individual Drugs Analysis”.

Hydroxyzine Use

Example 2

Antihistamines as ACE2 receptor modulators

Diphenhydramine

R-Azelastine

S-Azelastine

Hydroxyzine

S-Cetirizine

R-Cetirizine

Example 3

Influence of Antihistamines On Spike Proteins’ Ability To Penetrate Cells

Click here to view the patent on Google Patents.